Obesity Trial, Recruiting NCT05619705 Sponsor: Johns Hopkins University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT05619705
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are pregnant and at 33 weeks of pregnancy or earlier
  • People who are carrying one baby (not twins, triplets, etc.)
  • People whose body weight before pregnancy falls into the overweight or obese range (a BMI of 25 or higher, based on self-reported height and weight before pregnancy)
  • People who are able to give their informed agreement to take part in the study
  • People who speak English or Spanish
  • People who have completed the study's screening and initial information collection steps
  • People who are willing to take part in the study activities, such as weighing themselves at home and providing data throughout the study

Who may not be able to join:

  • People who have Type 1 diabetes or who were taking insulin before giving birth
  • People who are pregnant with more than one baby (such as twins or triplets)
  • People who are unable to walk one block without experiencing pain or shortness of breath
  • People who have not been cleared to participate by the study's medical team or home visiting program staff
  • People who are planning to move away from the local area within the next year
  • People who currently have an active substance use disorder (marijuana is an exception to this rule — confirm with trial site)
  • People who have been hospitalised for mental health or substance use reasons in the past year
  • People who currently have an active eating disorder

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kelly Bower, PhD, MSN/MPH, Johns Hopkins School of Nursing

Phone: 410-955-4280

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 April 2023
Est. completion
15 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in postpartum weight (retention)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov